November 13, 2014
2 min read
Save

Intraluminal shunt occlusion controls IOP, minimizes hypotony

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Intraluminal occlusion of a glaucoma shunt enabled controlled IOP reduction and low rates of hypotony and other complications, according to a study.

Perspective from Douglas J. Rhee, MD

The prospective study included 116 eyes of 112 patients who underwent Baerveldt tube (Abbott Medical Optics) implantation. The most common diagnoses were open-angle glaucoma, angle closure and pseudoexfoliation.

The main outcome measure was transient or persistent hypotony, defined as IOP of 5 mm Hg or lower, or hypertony, defined as IOP exceeding 21 mm Hg. Patients were followed for 1 year.

Mean preoperative IOP was 26.9 mm Hg with a mean of three glaucoma medications.

During the first year, 30 eyes (26%) underwent laser suture lysis and 93 eyes (80%) underwent stent removal.

Transient hypotony occurred in one case, transient hypertony in 10 cases and persistent hypertony in three cases; no cases of persistent hypotony were reported.

IOP was 5 mm Hg or lower in nine eyes at one or more time points. Eight eyes (7%) developed hypotony-related complications.

Mean IOP at 1 year was 12.8 mm Hg with a mean of 1.1 glaucoma medications.

Postoperative complications occurred in 11 eyes (9%).

Qualified success with or without medications was achieved in 94% of eyes and complete success was achieved in 32% of eyes at 12 months.

Disclosure: The authors have no relevant financial disclosures.